Delivery Order SPE2DB24D1104-SPE2DB24FXVW3
Award Date 3/22/24
Potential Completion Date 3/25/24
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Pulmozyme 1 mg/ml ampul 2.5 ml. The firm-fixed-price contract has a ceiling value of $2,583.60 and a period of performance through April 28, 2025. The contract is not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Pulmozyme 1 mg/ml ampul 2.5ml. The contract has a ceiling value of $5,444.32 and an ultimate completion date of January 14, 2025. It is a firm-fixed price delivery order contract, with no set-aside designation. AmerisourceBergen Drug Corp is the prime contractor, and the contract is associated with a larger Indefinite Delivery...
- The U.S. government awarded a $20,963.60 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, which has no set-aside designation, is for the provision of Pulmozyme 1 mg/ml ampul 2.5 ml to the Department of Defense (DoD) and its Medical Supply Chain agency. Amerisourcebergen, a major pharmaceutical distributor, holds significant Indefinite Delivery Contracts (IDCs) with the Defense Logistics Agency (DLA) Troop Support Medical for up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $14,881.52, is for the delivery of Pulmozyme 1 mg/ml ampul 2.5 ml, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of May 22, 2023. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Pulmozyme 1 mg/ml ampuls. The contract, valued at $32,686.58, is a firm-fixed-price delivery order with an ultimate completion date of January 19, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) has awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Pulmozyme 1 mg/mL ampul 2.5 mL. The $2,410.99 firm fixed-price contract has a completion date of March 22, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA for a wide range of pharmaceutical products and medical supplies to support the Department of Defense worldwide. This...
- The U.S. government has awarded a Delivery Order contract (SPE2DX15D1022|SPE2DX24FVDJJ) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to supply the pharmaceutical product Pulmozyme 1 mg/ml Ampul 2.5 ml. The contract has a ceiling value of $20,979.35 and has an ultimate completion date of February 8, 2024. The contract is a Firm Fixed Price award, and there was no set-aside designation used. The contracting agency is the Defense Logistics Agency (DLA) Troop Support Medical, a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $12,954.38 firm-fixed-price contract is for the supply of Pulmozyme 1 mg/mL ampul 2.5 mL, a medication used to treat cystic fibrosis. The contract has a period of performance through May 2, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $58,616.37, is for the supply of Pulmozyme 1 mg/mL ampules (2.5 mL) to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract is not set aside for any specific business type. AmerisourceBergen...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Pulmozyme 1 mg/ml ampul 2.5 ml. The order has a firm fixed price of $12,897.09 and a completion date of August 20, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as the primary vehicle for providing a comprehensive range...